Scandion Oncology A/S financials at a glance

The revenue of Scandion Oncology A/S is reported as 0 billion Kronor in the fiscal year 2023. The earnings were -2.78 Kronor per share in 2023, which was 22.47 lower than 2021. And about -0.06985 billion Kronor are reported as free cash flow in the financials of Scandion Oncology A/S 2023. No dividends were paid to the shareholders of the Scandion Oncology A/S stock OM:SCOL in the financial year 2023.